Bulut, Mahmut

Adenosine Deaminase, Nitric Oxide, Superoxide Dismutase, and Xanthine Oxidase in Patients with Major Depression: Impact of Antidepressant Treatment

Herken, H., Gurel, A., Selek, S., Armutcu, F., Ozen, M. E., Bulut, M., Kap, O., Yumru, M., Savas, H. A., & Akyol, O. (2007) · Archives of Medical Research

Tryptophan and brain disordersTreatment of Major Depression

Cited by 322

Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy

Atli, A., Demir, S., Bulut, M., Okan İbiloğlu, A., Güneş, M., Kaya, M., Demirpençe, Ö., & Sır, A. (2015) · Neuropsychiatric Disease and Treatment

Tryptophan and brain disordersTreatment of Major Depression

Cited by 156

Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia

Bulut, M., Savas, H. A., Altindag, A., Virit, O., & Dalkilic, A. (2009) · The World Journal of Biological Psychiatry

Schizophrenia research and treatmentTryptophan and brain disorders

Cited by 73

Somatosensory Amplification, Anxiety, and Depression in Patients With Hepatitis B: Impact on Functionality

Yilmaz, A., Ucmak, F., Dönmezdil, S., Kaya, M. C., Tekin, R., Günes, M., Arslan, N., & Bulut, M. (2016) · Medicine

Hepatitis B Virus StudiesPsychosomatic Disorders and Their Treatments

Cited by 14